Loading...

GSK plc

GSK•NYSE
Healthcare
Drug Manufacturers - General
$54.44
$-1.19(-2.14%)
U.S. Market opens in 15h 23m

GSK plc (GSK) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap109.6B
P/E Ratio14.15
EPS (TTM)$3.74
ROE0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$60.91
3 Months$66.58
1 Year Target$56.17

GSK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GSK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $56.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.15 and a market capitalization of 109.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.16%
5-Day Change
-5.65%
1-Month Change
2.80%
3-Month Change
10.74%
6-Month Change
25.88%
Year-to-Date (YTD) Change
10.99%
1-Year Change
45.15%
3-Year Change
48.51%
5-Year Change
44.07%
All-Time (Max) Change
8194.10%

Contact Information

https://www.gsk.com
44 20 8047 5000
980 Great West Road, Brentford, NaN, TW8 9GS

Company Facts

68,629 Employees
IPO DateMar 28, 1980
CountryGB
Actively Trading

Frequently Asked Questions